Commentary on Novitas LCD
Bladder Cancer
.
2023 Dec 13;9(4):305-312.
doi: 10.3233/BLC-230057.
eCollection 2023.
Authors
Yair Lotan
1
,
Daniel A Barocas
2
,
Sam S Chang
2
,
Siamak Daneshmand
3
,
Badrinath Konety
4
,
Joshua J Meeks
5
,
Sima Porten
6
,
Jay D Raman
7
,
Charles J Rosser
8
,
Kristen R Scarpato
2
,
Wade J Sexton
9
,
John P Sfakianos
10
,
Neal D Shore
11
,
Robert S Svatek
12
Affiliations
1
University of Texas Southwestern, Dallas, TX, USA.
2
Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA.
3
Department of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
4
Allina Health Cancer Institute, Minneapolis, MN, USA and University of Minnesota, Minneapolis, MN, USA.
5
Department of Urology and Biochemistry, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
6
Department of Urology, University of San Francisco, San Fransisco, CA, USA.
7
Department of Urology, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.
8
Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
9
Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA.
10
Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
11
Carolina Urologic Research Center, Myrtle Beach, SC, USA.
12
Department of Urology, UT Health San Antonio, San Antonio, TX, USA.
PMID:
38994243
PMCID:
PMC11165914
DOI:
10.3233/BLC-230057
No abstract available